Home > Products > B cell lymphoma BCL1 Idiotype & CD64 > Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Miniantibody)

Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Miniantibody)  (CAT#: MNAB-001)

Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-B cell lymphoma BCL1 Idiotype antibody variable domain is linked to another scFv of an anti-CD64 antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can retarget immune cells to tumor cells. It is designed for the research of B cell lymphoma therapy.
Datasheet INQUIRY

Specifications

Targets
B cell lymphoma BCL1 Idiotype & CD64
Type
Miniantibody
Species Reactivity
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma

Targets

Target 1
B cell lymphoma BCL1 Idiotype
Alternative Names
B cell lymphoma BCL1 Idiotype; B cell lymphoma; BCL1; Idiotype; Id; 31D1; 32D1
Target 2
CD64
Gene ID
UniProt ID
Alternative Names
FcγRI; FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64); CD64; FCRI; CD64A; IGFR1; high affinity immunoglobulin gamma Fc receptor I; fcgammaRIa; Fc-gamma RI; fc-gamma RIA; Fc gamma receptor; IgG Fc receptor I; Fc-gamma receptor I A1; Fc fragment of IgG, high affinity Ia, receptor for (CD64); FCGR1B, FCGR1C
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Miniantibody) (MNAB-001). Click the button below to contact us or submit your feedback about this product.